• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

HD Biosciences

edit

HD Biosciences Inc. (HDB) is a Shanghai-based biotech company specializing in drug discovery contract research. HDB has developed extensive knowledge and comprehensive technology platforms for drug discovery including assay development, high throughput drug screening, SAR, closed-loop and hit-to-lead biology solutions, as well as natural product-based lead discovery. The Company has signed multiple-year research agreements with clients including Pfizer, Organon and other pharmaceutical and biotech clients and is an indisputable leader in high value-added biology-based drug discovery CRO business in China.

Milestones

edit

• 
  HD Biosciences added Peiyuan Lin as Senior Vice President, Discovery Biology.
  Posted 6/23/09 at 10:50pm
• 
  HD Biosciences added Xuehai Tan as CEO & President, Chairman of the Board.
  Posted 6/23/09 at 10:50pm
• 
  HD Biosciences received in Series A funding. (8/8/08)
  Posted 6/23/09 at 11:03pm via equityhelpdesk.com

Videos

Screenshots

edit

Above: HD Biosciences
Uploaded: 6/24/09

Sources

1. HD Biosciences Raises First Round (equityhelpdesk.com) [edit]